Suppr超能文献

采用体外先进仿生肠反应器研究黏蛋白阿克曼氏菌的生长、代谢和形态。

Study of growth, metabolism, and morphology of Akkermansia muciniphila with an in vitro advanced bionic intestinal reactor.

机构信息

Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.

Wuxi Galaxy Biotech Co. Ltd., Wuxi, 214125, China.

出版信息

BMC Microbiol. 2021 Feb 23;21(1):61. doi: 10.1186/s12866-021-02111-7.

Abstract

BACKGROUND

As a kind of potential probiotic, Akkermansia muciniphila abundance in human body is directly causally related to obesity, diabetes, inflammation and abnormal metabolism. In this study, A. muciniphila dynamic cultures using five different media were implemented in an in vitro bionic intestinal reactor for the first time instead of the traditional static culture using brain heart infusion broth (BHI) or BHI + porcine mucin (BPM).

RESULTS

The biomass under dynamic culture using BPM reached 1.92 g/L, which improved 44.36% compared with the value under static culture using BPM. The biomass under dynamic culture using human mucin (HM) further increased to the highest level of 2.89 g/L. Under dynamic culture using porcine mucin (PM) and HM, the main metabolites were short-chain fatty acids (acetic acid and butyric acid), while using other media, a considerable amount of branched-chain fatty acids (isobutyric and isovaleric acids) were produced. Under dynamic culture Using HM, the cell diameters reached 999 nm, and the outer membrane protein concentration reached the highest level of 26.26 μg/mg.

CONCLUSIONS

This study provided a preliminary theoretical basis for the development of A. muciniphila as the next generation probiotic.

摘要

背景

阿克曼氏菌作为一种潜在的益生菌,其在人体中的丰度与肥胖、糖尿病、炎症和代谢异常有直接的因果关系。本研究首次在体外仿生肠反应器中使用五种不同的培养基进行阿克曼氏菌动态培养,替代传统的使用脑心浸液培养基(BHI)或 BHI+猪黏蛋白(BPM)的静态培养。

结果

使用 BPM 进行动态培养的生物量达到 1.92g/L,与使用 BPM 进行静态培养的值相比提高了 44.36%。使用人黏蛋白(HM)进行动态培养的生物量进一步增加到最高水平 2.89g/L。在使用猪黏蛋白(PM)和 HM 进行动态培养时,主要代谢产物为短链脂肪酸(乙酸和丁酸),而在使用其他培养基时,会产生相当数量的支链脂肪酸(异丁酸和异戊酸)。在使用 HM 进行动态培养时,细胞直径达到 999nm,外膜蛋白浓度达到最高水平 26.26μg/mg。

结论

本研究为开发阿克曼氏菌作为下一代益生菌提供了初步的理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/7901181/75442c848215/12866_2021_2111_Fig1_HTML.jpg

相似文献

5
In vitro co-metabolism of epigallocatechin-3-gallate (EGCG) by the mucin-degrading bacterium Akkermansia muciniphila.
PLoS One. 2021 Dec 2;16(12):e0260757. doi: 10.1371/journal.pone.0260757. eCollection 2021.
6
Mucin degrader accelerates intestinal stem cell-mediated epithelial development.
Gut Microbes. 2021 Jan-Dec;13(1):1-20. doi: 10.1080/19490976.2021.1892441.
7
A review of a potential and promising probiotic candidate-Akkermansia muciniphila.
J Appl Microbiol. 2021 Jun;130(6):1813-1822. doi: 10.1111/jam.14911. Epub 2020 Nov 15.
9
A next generation probiotic, .
Crit Rev Food Sci Nutr. 2019;59(19):3227-3236. doi: 10.1080/10408398.2018.1517725. Epub 2018 Oct 29.
10
Binding of Akkermansia muciniphila to mucin is O-glycan specific.
Nat Commun. 2024 May 29;15(1):4582. doi: 10.1038/s41467-024-48770-8.

引用本文的文献

1
Contribution of farms to the microbiota in the swine value chain.
Front Syst Biol. 2023 Jul 12;3:1183868. doi: 10.3389/fsysb.2023.1183868. eCollection 2023.
2
Effect of on GLP-1 and Insulin Secretion.
Nutrients. 2025 Jul 31;17(15):2516. doi: 10.3390/nu17152516.
3
Breaking down barriers: is intestinal mucus degradation by beneficial or harmful?
Infect Immun. 2025 Sep 9;93(9):e0050324. doi: 10.1128/iai.00503-24. Epub 2025 Aug 11.
5
Microbes Matter: Exploring the Connection Between Infant Gut Microbiota and Bone Development.
Calcif Tissue Int. 2025 Jun 27;116(1):90. doi: 10.1007/s00223-025-01395-5.
8
Altered Gut Microbiota Contributes to Acute-Respiratory-Distress-Syndrome-Related Depression through Microglial Neuroinflammation.
Research (Wash D C). 2025 Mar 19;8:0636. doi: 10.34133/research.0636. eCollection 2025.
10
Akkermansia muciniphila: promises and pitfallsfor next-generation beneficial microorganisms.
Arch Microbiol. 2025 Mar 4;207(4):76. doi: 10.1007/s00203-025-04263-w.

本文引用的文献

1
-Derived Extracellular Vesicles as a Mucosal Delivery Vector for Amelioration of Obesity in Mice.
Front Microbiol. 2019 Oct 1;10:2155. doi: 10.3389/fmicb.2019.02155. eCollection 2019.
2
Strain-Specific Anti-inflammatory Properties of Two Strains on Chronic Colitis in Mice.
Front Cell Infect Microbiol. 2019 Jul 5;9:239. doi: 10.3389/fcimb.2019.00239. eCollection 2019.
3
Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice.
Nat Med. 2019 Aug;25(8):1234-1242. doi: 10.1038/s41591-019-0504-5. Epub 2019 Jul 22.
4
Potential roles of gut microbiome and metabolites in modulating ALS in mice.
Nature. 2019 Aug;572(7770):474-480. doi: 10.1038/s41586-019-1443-5. Epub 2019 Jul 22.
5
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.
Nat Med. 2019 Jul;25(7):1096-1103. doi: 10.1038/s41591-019-0495-2. Epub 2019 Jul 1.
6
Akkermansia muciniphila is a promising probiotic.
Microb Biotechnol. 2019 Nov;12(6):1109-1125. doi: 10.1111/1751-7915.13410. Epub 2019 Apr 21.
8
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases.
Nat Genet. 2019 Apr;51(4):600-605. doi: 10.1038/s41588-019-0350-x. Epub 2019 Feb 18.
10
Strategies to promote abundance of , an emerging probiotics in the gut, evidence from dietary intervention studies.
J Funct Foods. 2017 Jun;33:194-201. doi: 10.1016/j.jff.2017.03.045. Epub 2017 Mar 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验